Join @laurenmerzmd.bsky.social at 5 PM PST on @ash-hematology.bsky.social’s virtual platform during the #ASH24 poster walk highlighting her work, Assessing the Contribution of Duffy Null Phenotype to Disparities in Eligibility Criteria for Clinical Trials for Newly-Diagnosed Colorectal Cancer.

Come talk with me today at 1:15 about universal Duffy testing and how we optimally use the new Duffy null specific ANC reference intervals! #ASH24

If we ignore Duffy-null associated neutrophil counts (DANC), we contribute to major disparities in oncology care and clinical trial enrollment. Whether you’re a clinical trialist or clinician, a must-read from @laurenmerzmd.bsky.social and coauthors #medsky #hemesky 🩸🧪 www.nejm.org/doi/abs/10.1...

Many absolute neutrophil count thresholds in cancer care do not account for normal levels in people with the Duffy null phenotype— the majority of whom are Black or Middle Eastern. 👇Check out some strategies we propose to address systemic racism in cancer care! www.nejm.org/doi/full/10....